Phase I/II clinical trial - Pédiatrie Sarcomes
ZN-c3-003
Pédiatrie Sarcomes
Essai clinique fermé
Public cible
Enfant
A Phase 1/2 Dose Escalation and Dose Expansion Study of ZN-c3 in Combination With Gemcitabine in Adult and Pediatric Subjects With Relapsed or Refractory Osteosarcoma
Description de l'essai
This is a phase 1/2 study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.
Liens utiles
ISABELLE AERTS
Investigateur principal